X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20924) 20924
Book Review (3697) 3697
Publication (864) 864
Newsletter (573) 573
Book Chapter (341) 341
Conference Proceeding (139) 139
Book / eBook (122) 122
Newspaper Article (84) 84
Magazine Article (75) 75
Dissertation (47) 47
Web Resource (12) 12
Journal / eJournal (7) 7
Reference (7) 7
Data Set (6) 6
Government Document (3) 3
Streaming Video (3) 3
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14995) 14995
humans (13754) 13754
male (8320) 8320
female (7263) 7263
middle aged (4702) 4702
clinical neurology (4403) 4403
adult (4376) 4376
neurosciences (4277) 4277
animals (3798) 3798
dyskinesia (3685) 3685
psychiatry (3663) 3663
aged (3375) 3375
parkinson's disease (3138) 3138
antipsychotic agents - adverse effects (2922) 2922
tardive dyskinesia (2776) 2776
dyskinesia, drug-induced - etiology (2720) 2720
tardive-dyskinesia (2499) 2499
pharmacology & pharmacy (2465) 2465
movement disorders (2423) 2423
schizophrenia (2089) 2089
parkinson disease - drug therapy (1900) 1900
schizophrenia - drug therapy (1828) 1828
rats (1761) 1761
antipsychotic agents - therapeutic use (1723) 1723
dyskinesia, drug-induced - drug therapy (1559) 1559
abridged index medicus (1533) 1533
adolescent (1511) 1511
dyskinesias (1475) 1475
treatment outcome (1475) 1475
levodopa - adverse effects (1466) 1466
dopamine (1431) 1431
dyskinesia, drug-induced - physiopathology (1394) 1394
basal ganglia (1353) 1353
neurology (1319) 1319
levodopa (1311) 1311
parkinsons-disease (1311) 1311
primary ciliary dyskinesia (1243) 1243
child (1238) 1238
dose-response relationship, drug (1158) 1158
antiparkinson agents - adverse effects (1088) 1088
haloperidol (1018) 1018
disease models, animal (1011) 1011
double-blind (1007) 1007
dyskinesia, drug-induced - diagnosis (1002) 1002
research (994) 994
levodopa - therapeutic use (955) 955
antiparkinson agents - therapeutic use (950) 950
risk factors (938) 938
time factors (926) 926
anti-dyskinesia agents - therapeutic use (903) 903
dystonia (894) 894
analysis (885) 885
parkinson disease - physiopathology (855) 855
care and treatment (829) 829
l-dopa (788) 788
severity of illness index (779) 779
rats, sprague-dawley (767) 767
dyskinesias - etiology (757) 757
disease (747) 747
levodopa-induced dyskinesia (746) 746
levodopa-induced dyskinesias (733) 733
brain (726) 726
antipsychotic drugs (715) 715
motor fluctuations (709) 709
diagnosis (702) 702
pediatrics (694) 694
aged, 80 and over (689) 689
mice (684) 684
surgery (682) 682
botulinum toxins - therapeutic use (679) 679
schizophrenic psychology (678) 678
drug therapy (677) 677
follow-up studies (657) 657
clozapine (654) 654
children (640) 640
prevalence (630) 630
medicine & public health (622) 622
drugs (621) 621
child, preschool (616) 616
antipsychotic agents - administration & dosage (613) 613
diagnosis, differential (610) 610
drug therapy, combination (610) 610
double-blind method (597) 597
psychiatric status rating scales (596) 596
old medline (582) 582
dopa (571) 571
motor activity - drug effects (571) 571
striatum (571) 571
medical research (569) 569
neurons (558) 558
dopamine - metabolism (557) 557
psychotic disorders - drug therapy (547) 547
medicine, general & internal (539) 539
magnetic resonance imaging (534) 534
retrospective studies (532) 532
neuroleptics (529) 529
dopa-induced dyskinesia (528) 528
health aspects (512) 512
parkinson disease - complications (512) 512
dyskinesias - physiopathology (510) 510
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (69) 69
Online Resources - Online (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (14) 14
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Gerstein Science - Circulation Desk (5) 5
Providence Healthcare - Stacks (5) 5
Holland Bloorview Kids Rehabilitation - Stacks (4) 4
Baycrest Hospital - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Missing (2) 2
Providence Healthcare - Reference (2) 2
St. Michael's Hospital - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
West Park Healthcare Centre - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
OISE - Lost (1) 1
OISE - Stacks (1) 1
Robarts - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19544) 19544
French (574) 574
German (520) 520
Spanish (359) 359
Russian (342) 342
Japanese (171) 171
Italian (133) 133
Portuguese (93) 93
Polish (68) 68
Czech (56) 56
Chinese (47) 47
Dutch (37) 37
Turkish (37) 37
Hungarian (36) 36
Romanian (27) 27
Danish (26) 26
Ukrainian (17) 17
Korean (15) 15
Swedish (15) 15
Norwegian (12) 12
Bulgarian (11) 11
Finnish (10) 10
Hebrew (8) 8
Serbian (6) 6
Persian (3) 3
Bosnian (2) 2
Croatian (2) 2
Slovak (2) 2
Estonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2005, 2nd ed., ISBN 1405126191, xiv, 466
An invaluable addition to the library of any neurologist, this book updates and presents the current state of the art clinical approaches to this subject,... 
Neuroleptic malignant syndrome | Side effects | Antipsychotic drugs | Akathisia, Drug-Induced | Dyskinesia, Drug-Induced | Tardive dyskinesia | Movement Disorders | classification | Antiparkinsonian agents | etiology
Book
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 818 - 828
Foetal cell transplantation in patients with Parkinson’s disease can induce motor complications independent of -DOPA administration, known as graft-induced... 
Graft | Receptors | Dopamine | L-3,4-dihydroxyphenylalanine | Methamphetamine | Dyskinesia | FETAL NIGRAL TRANSPLANTATION | DOPA-INDUCED DYSKINESIA | VENTRAL MESENCEPHALIC GRAFTS | CELL TRANSPLANTATION | ABNORMAL INVOLUNTARY MOVEMENTS | NEUROSCIENCES | BEHAVIORAL RECOVERY | LEVODOPA-INDUCED DYSKINESIA | IN-VIVO | PHARMACOLOGY & PHARMACY | DEEP BRAIN-STIMULATION | MEDIUM SPINY NEURONS | Excitatory Amino Acid Antagonists - therapeutic use | Mesencephalon - cytology | Dopamine Antagonists - administration & dosage | Neostriatum - metabolism | Anti-Dyskinesia Agents - administration & dosage | Neurons - metabolism | Disease Models, Animal | Neostriatum - pathology | Cell Transplantation - adverse effects | Nerve Tissue Proteins - agonists | Excitatory Amino Acid Antagonists - administration & dosage | Rats | Dopamine Antagonists - therapeutic use | Random Allocation | Dyskinesia, Drug-Induced - pathology | Rats, Sprague-Dawley | Dyskinesias - metabolism | Receptors, Neurotransmitter - metabolism | Dyskinesia, Drug-Induced - metabolism | Serotonin Receptor Agonists - metabolism | Dyskinesias - drug therapy | Excitatory Amino Acid Antagonists - metabolism | Parkinson Disease - therapy | Neurons - pathology | Mesencephalon - metabolism | Methamphetamine - toxicity | Dose-Response Relationship, Drug | Neurons - transplantation | Neostriatum - drug effects | Dyskinesia, Drug-Induced - drug therapy | Dopamine Antagonists - metabolism | Female | Neurons - drug effects | Excitatory Amino Acid Antagonists - adverse effects | Nerve Tissue Proteins - antagonists & inhibitors | Receptors, Neurotransmitter - antagonists & inhibitors | Dyskinesias - pathology | Anti-Dyskinesia Agents - metabolism | Dyskinesias - etiology | Dopamine Uptake Inhibitors - administration & dosage | Nerve Tissue Proteins - metabolism | Anti-Dyskinesia Agents - therapeutic use | Serotonin Receptor Agonists - therapeutic use | Animals | Anti-Dyskinesia Agents - adverse effects | Mesencephalon - embryology | Receptors, Neurotransmitter - agonists | Methamphetamine - administration & dosage | Dopamine Uptake Inhibitors - toxicity | Serotonin Receptor Agonists - administration & dosage | Methyl aspartate | Movement disorders | Parkinson's disease | Index Medicus | Amantadine | Animal models | Neurodegenerative diseases | Serotonin | Glutamic acid receptors (ionotropic) | N-Methyl-D-aspartic acid receptors | yohimbine | Antagonists | Cannabinoid CB1 receptors | Serotonin S1 receptors | MK-801 | Amphetamine | Naloxone | 8-Hydroxy-2-(di-n-propylamino)tetralin | Glutamatergic transmission | Glutamic acid receptors (metabotropic)
Journal Article
Journal Article
2012, 1. Aufl., ISBN 1444333526, 408
Hyperkinetic movement disorders comprise a range of diseases characterized by unwanted and uncontrollable, or poorly controllable, involuntary movements. The... 
Neurology | Hyperkinesia | Diagnosis, Differential | Diagnosis
eBook
Movement Disorders, ISSN 0885-3185, 01/2007, Volume 22, Issue 2, pp. 193 - 197
We sought to review the long‐term tolerability of tetrabenazine (TBZ) and seek determinants of tolerability in the treatment of hyperkinetic movement... 
tetrabenazine | chorea | tics | tolerability | tardive dyskinesia | Tics | Tolerability | Tardive dyskinesia | Tetrabenazine | Chorea | OPEN-LABEL | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | TOURETTES-SYNDROME | DRUGS | NEUROLEPTIC MALIGNANT SYNDROME | DOUBLE-BLIND | TARDIVE-DYSKINESIA | HUNTINGTONS-DISEASE | BRAIN | Prevalence | Dyskinesia, Drug-Induced - physiopathology | Humans | Middle Aged | Drug Tolerance - physiology | Male | Hyperkinesis - physiopathology | Time | Hyperkinesis - drug therapy | Tics - epidemiology | Myoclonus - drug therapy | Dyskinesia, Drug-Induced - drug therapy | Parkinsonian Disorders - drug therapy | Adult | Female | Anti-Dyskinesia Agents - administration & dosage | Retrospective Studies | Huntington Disease - physiopathology | Severity of Illness Index | Tetrabenazine - administration & dosage | Parkinsonian Disorders - physiopathology | Dyskinesia, Drug-Induced - epidemiology | Drug Administration Schedule | Parkinsonian Disorders - epidemiology | Huntington Disease - etiology | Myoclonus - physiopathology | Anti-Dyskinesia Agents - therapeutic use | Huntington Disease - epidemiology | Anti-Dyskinesia Agents - adverse effects | Age of Onset | Tetrabenazine - adverse effects | Hyperkinesis - epidemiology | Myoclonus - epidemiology | Tics - drug therapy | Tics - physiopathology | Tetrabenazine - therapeutic use | Index Medicus
Journal Article
Short Reports - Cerebrotendinous xanthomatosis with oromandibular dyskinesia, 12/2003
We present an unusual case of cerebrotendinous xanthomatosis in a female elderly patient with recurrent TM joint dislocation and oromandibular dyskinesia. 
Cerebrotendinous xanthomatosis, Oromandibular dyskinesia
Journal
Neurobiology of Disease, ISSN 0969-9961, 2014, Volume 74, pp. 295 - 304
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 07/2011, Volume 118, Issue 1, pp. 12 - 23
L-DOPA is the most commonly used treatment for symptomatic control in patients with Parkinson's disease. Unfortunately, most patients develop severe... 
chronoamperometry | SERT | 5‐HT | DOPA‐induced dyskinesia | 5-HT | l- DOPA-induced dyskinesia | IN-VIVO MICRODIALYSIS | EXTRACELLULAR DOPAMINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MODEL | 5-HT1A RECEPTOR STIMULATION | SUBSTANTIA-NIGRA | NEUROSCIENCES | EXOGENOUS L-DOPA | LEVODOPA-INDUCED DYSKINESIA | L-DOPA-induced dyskinesia | 6-HYDROXYDOPAMINE LESIONED RATS | STRIATUM | PARKINSONS-DISEASE | Severity of Illness Index | Tyrosine 3-Monooxygenase - metabolism | Dyskinesia, Drug-Induced - physiopathology | Presynaptic Terminals - drug effects | Stereotyped Behavior - drug effects | Rats | Levodopa - toxicity | Dyskinesia, Drug-Induced - pathology | Rats, Sprague-Dawley | Adrenergic Agents - toxicity | Dopa Decarboxylase - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Oxidopamine - toxicity | Animals | Apomorphine - pharmacology | Potassium Chloride - pharmacology | Serotonin - metabolism | Functional Laterality - drug effects | Presynaptic Terminals - metabolism | Female | Electrochemistry - methods | Corpus Striatum - pathology | Dopamine - metabolism | Disease Models, Animal | Phenols | Neurosciences | Dopamine | Parkinson's disease | Serotonin | Neurochemistry | Neurotransmitters | Side effects | Pharmacology | Parkinsons disease | Index Medicus | Neurodegenerative diseases | Innervation | Neostriatum | Nerves | Levodopa | Movement disorders | Dyskinesia | Fibers | Chronoamperometry | L-DOPA induced dyskinesia | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Cell and Molecular Biology | Cell- och molekylärbiologi
Journal Article
2010, Second edition, ISBN 9780750698528, xi, 279
Movement Disorders in Childhood, Second Edition, provides the most up-to-date information on the diseases and disorders that affect motor control, an important... 
Movement disorders in children | Clinical & internal medicine
Book
Journal Article